financetom
Business
financetom
/
Business
/
goeasy Announces US$400 Million and C$100 Million Notes Offerings
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
goeasy Announces US$400 Million and C$100 Million Notes Offerings
Aug 12, 2025 7:40 AM

09:58 AM EDT, 08/12/2025 (MT Newswires) -- goeasy (GSY.TO), on Tuesday said it plans to offer US$400 million and C$100 million offerings of senior unsecured notes. The CAD notes will have substantially identical terms as, and will be treated as a single series with goeasy's 6% senior unsecured notes due 2030 that were issued last November.

The actual terms of the USD notes, including interest rate, will depend on market conditions at the time of pricing. goeasy also expects to enter into a currency swap agreement to fix the foreign currency exchange rate for the proceeds from USD notes offering.

Proceeds from the sale of the notes will be used to pay down debt.

The company's shares are up $1.40, to $208, on the Toronto Stock Exchange.

Price: 207.58, Change: +0.98, Percent Change: +0.47

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Halozyme Therapeutics Insider Sold Shares Worth $4,167,930, According to a Recent SEC Filing
Halozyme Therapeutics Insider Sold Shares Worth $4,167,930, According to a Recent SEC Filing
Nov 13, 2025
03:56 AM EST, 11/13/2025 (MT Newswires) -- Helen Torley, Director, President and Chief Executive Officer, on November 10, 2025, sold 60,000 shares in Halozyme Therapeutics ( HALO ) for $4,167,930. Following the Form 4 filing with the SEC, Torley has control over a total of 733,719 common shares of the company, with 733,719 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1159036/000115903625000054/xslF345X05/wk-form4_1762991674.xml ...
SBC Medical Group Announces Commencement of Tender Offer for Shares of Waqoo, Inc.
SBC Medical Group Announces Commencement of Tender Offer for Shares of Waqoo, Inc.
Nov 13, 2025
TOKYO--(BUSINESS WIRE)-- SBC Medical Group Holdings Incorporated ( SBC ) , a global provider of comprehensive consulting and management services to the medical corporations and their clinics, today announced that on November 13, 2025, SBC Medical Group Co., Ltd. (the “Tender Offeror”) has resolved to acquire shares of common stock of Waqoo, Inc. through a tender offer (the “Tender Offer”)...
Carvana Insider Sold Shares Worth $3,250,300, According to a Recent SEC Filing
Carvana Insider Sold Shares Worth $3,250,300, According to a Recent SEC Filing
Nov 13, 2025
03:55 AM EST, 11/13/2025 (MT Newswires) -- Ryan S. Keeton, Chief Brand Officer, on November 10, 2025, sold 10,000 shares in Carvana ( CVNA ) for $3,250,300. Following the Form 4 filing with the SEC, Keeton has control over a total of 104,958 Class A common shares of the company, with 104,958 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1690820/000170054225000011/xslF345X05/wk-form4_1762991500.xml ...
Adaptive Biotechnologies Insider Sold Shares Worth $1,315,180, According to a Recent SEC Filing
Adaptive Biotechnologies Insider Sold Shares Worth $1,315,180, According to a Recent SEC Filing
Nov 13, 2025
03:54 AM EST, 11/13/2025 (MT Newswires) -- Chad M Robins, Director, Chief Executive Officer and Chairman, on November 10, 2025, sold 89,265 shares in Adaptive Biotechnologies ( ADPT ) for $1,315,180. Following the Form 4 filing with the SEC, Robins has control over a total of 2,869,975 common shares of the company, with 2,869,975 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1478320/000178064925000002/xslF345X05/primary_doc.xml...
Copyright 2023-2026 - www.financetom.com All Rights Reserved